Principal Financial Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,925
Closed -$914K 2337
2025
Q1
$914K Sell
6,925
-544,038
-99% -$67.8M ﹤0.01% 1864
2024
Q4
$46M Sell
550,963
-46,750
-8% -$3.84M 0.03% 486
2024
Q3
$43.7M Buy
597,713
+18,865
+3% +$1.42M 0.02% 509
2024
Q2
$39.6M Buy
578,848
+51,480
+10% +$3.57M 0.02% 544
2024
Q1
$36.5M Buy
527,368
+66,802
+15% +$4.59M 0.02% 598
2023
Q4
$33M Buy
460,566
+44,564
+11% +$2.56M 0.02% 594
2023
Q3
$21.7M Sell
416,002
-1,832
-0.4% -$107K 0.02% 763
2023
Q2
$26.5M Buy
417,834
+394,508
+1,691% +$24.6M 0.02% 681
2023
Q1
$1.26M Sell
23,326
-1,603
-6% -$77.5K ﹤0.01% 1826
2022
Q4
$1.32M Sell
24,929
-20,947
-46% -$1.05M ﹤0.01% 1826
2022
Q3
$2.13M Sell
45,876
-146,465
-76% -$7.65M ﹤0.01% 1705
2022
Q2
$11M Buy
192,341
+126,338
+191% +$7.16M 0.01% 1198
2022
Q1
$4.04M Sell
66,003
-577
-0.9% -$30K ﹤0.01% 1732
2021
Q4
$3.48M Buy
66,580
+35,208
+112% +$1.48M ﹤0.01% 1766
2021
Q3
$1.17M Buy
31,372
+1,392
+5% +$48.4K ﹤0.01% 1973
2021
Q2
$1.22M Buy
29,980
+5,364
+22% +$198K ﹤0.01% 1999
2021
Q1
$835K Buy
24,616
+1,724
+8% +$59.8K ﹤0.01% 2032
2020
Q4
$728K Buy
22,892
+9,117
+66% +$240K ﹤0.01% 2015
2020
Q3
$353K Sell
13,775
-194
-1% -$4.43K ﹤0.01% 2095
2020
Q2
$359K Buy
+13,969
New +$283K ﹤0.01% 2051
2020
Q1
Sell
-8,054
Closed -$276K 2260
2019
Q4
$276K Buy
+8,054
New +$96.7K ﹤0.01% 2070
2016
Q1
Sell
-4,601
Closed -$247K 2204
2015
Q4
$247K Buy
+4,601
New +$232K ﹤0.01% 1998

Other funds holding ITCI